Revolutionary COPD treatment: FDA approves Verona Pharma’s Ohtuvayre - sales to hit $1.1BN by 2029 27-Jun-2024 By Liza Laws The US Food and Drug Administration (FDA) has approved Verona Pharma’s Ohtuvayre (ensifentrine), marking a significant milestone in the treatment of chronic obstructive pulmonary disease (COPD).